Literature DB >> 8319713

Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency--diagnosis, plasma carnitine fractions and management in a further patient.

R Moore1, J F Glasgow, M A Bingham, J A Dodge, R J Pollitt, S E Olpin, B Middleton, K Carpenter.   

Abstract

Long-chain 3-hydroxyacyl-coenzyme A dehydrogenase (LCHAD), the third enzyme of the mitochondrial beta-oxidation pathway, carries out the dehydrogenation of 3-hydroxyacyl-CoA compounds of 12-18 carbon length. To date only nine cases of LCHAD deficiency have been documented. We report a further patient who as a neonate developed non-specific gastrointestinal symptoms and at 5 months of age cardiomyopathy, recurrent hypoketotic hypoglycaemia and gross alterations of plasma carnitine fractions. Dietary management with medium chain triglycerides led rapidly to clinical improvement. There was a close correlation between the clinical condition, plasma carnitine fractions and cardiac function. At 2 years of age she is developing normally.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8319713     DOI: 10.1007/bf01955905

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  22 in total

1.  Progressive neuropathy and recurrent myoglobinuria in a child with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency.

Authors:  C Dionisi Vici; A B Burlina; E Bertini; C Bachmann; M R Mazziotta; F Zacchello; G Sabetta; D E Hale
Journal:  J Pediatr       Date:  1991-05       Impact factor: 4.406

2.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Authors:  R J Wanders; L IJlst; A H van Gennip; C Jakobs; J P de Jager; L Dorland; F J van Sprang; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

3.  The use of phenylpropionic acid as a loading test for medium-chain acyl-CoA dehydrogenase deficiency.

Authors:  J W Seakins; G Rumsby
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

4.  A simple screening test for medium-chain acyl CoA dehydrogenase deficiency.

Authors:  G Rumsby; J W Seakins; J V Leonard
Journal:  Lancet       Date:  1986-08-23       Impact factor: 79.321

5.  Sensitive assay of carnitine palmitoyl transferase activity in tissue homogenates with a modified spectrophotometric method for enzymatic carnitine determination.

Authors:  T Deufel; O H Wieland
Journal:  Clin Chim Acta       Date:  1983-12-15       Impact factor: 3.786

6.  The existence of an inner-membrane-bound, long acyl-chain-specific 3-hydroxyacyl-CoA dehydrogenase in mammalian mitochondria.

Authors:  M El-Fakhri; B Middleton
Journal:  Biochim Biophys Acta       Date:  1982-11-12

7.  3-Hydroxydicarboxylic aciduria due to long-chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency associated with sudden neonatal death: protective effect of medium-chain triglyceride treatment.

Authors:  M Duran; R J Wanders; J P de Jager; L Dorland; L Bruinvis; D Ketting; L Ijlst; F J van Sprang
Journal:  Eur J Pediatr       Date:  1991-01       Impact factor: 3.183

8.  Systemic carnitine deficiency. Report of a fatal case with multisystemic manifestations.

Authors:  A J Ware; W C Burton; J D McGarry; J F Marks; A G Weinberg
Journal:  J Pediatr       Date:  1978-12       Impact factor: 4.406

9.  Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity.

Authors:  A K Bhuiyan; K Bartlett; H S Sherratt; L Agius
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

10.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency.

Authors:  S Jackson; K Bartlett; J Land; E R Moxon; R J Pollitt; J V Leonard; D M Turnbull
Journal:  Pediatr Res       Date:  1991-04       Impact factor: 3.756

View more
  7 in total

1.  Substrate oxidation and cardiac performance during exercise in disorders of long chain fatty acid oxidation.

Authors:  Annie M Behrend; Cary O Harding; James D Shoemaker; Dietrich Matern; David J Sahn; Diane L Elliot; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2011-10-01       Impact factor: 4.797

2.  Retinal dystrophy in long chain 3-hydroxy-acyl-coA dehydrogenase deficiency.

Authors:  I Schrijver-Wieling; G H van Rens; D Wittebol-Post; J A Smeitink; J P de Jager; H B de Klerk; G H van Lith
Journal:  Br J Ophthalmol       Date:  1997-04       Impact factor: 4.638

3.  Acylcarnitines in plasma and blood spots of patients with long-chain 3-hydroxyacyl-coenzyme A dehydrogenase defiency.

Authors:  J L Van Hove; S G Kahler; M D Feezor; J P Ramakrishna; P Hart; W R Treem; J J Shen; D Matern; D S Millington
Journal:  J Inherit Metab Dis       Date:  2000-09       Impact factor: 4.982

Review 4.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: a severe fatty acid oxidation disorder.

Authors:  A C Sewell; S W Bender; S Wirth; H Münterfering; L Ijlist; R J Wanders
Journal:  Eur J Pediatr       Date:  1994-10       Impact factor: 3.183

5.  Lactic acidosis in long-chain fatty acid beta-oxidation disorders.

Authors:  F V Ventura; J P Ruiter; L IJlst; I T de Almeida; R J Wanders
Journal:  J Inherit Metab Dis       Date:  1998-08       Impact factor: 4.982

6.  Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy.

Authors:  J Schaefer; S Jackson; F Taroni; P Swift; D M Turnbull
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-02       Impact factor: 10.154

7.  What is the role of medium-chain triglycerides in the management of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency?

Authors:  A M Lund; M A Dixon; P Vreken; J V Leonard; A A M Morris
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.750

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.